Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis - Comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study

Mycoses

Volumn 50, Issue 1, 2007, Pages 35-40

  Watanabe, Shinichi ^a   Takahashi, Hisashi ^a   Nishikawa, Takeji ^b   Takiuchi, Iwao ^c   Higashi, Nobuhiko ^d   Nishimoto, Katsutaro ^e   Kagawa, Saburo ^f   Yamaguchi, Hideyo ^g   Ogawa, Hideoki ^h  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d SAKAI MUNICIPAL HOSPITAL   (Japan)

^e NAGASAKI UNIVERSITY   (Japan)

^f SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TEIKYO UNIVERSITY   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

New antimycotic: luliconazole; Phase II clinical study

Indexed keywords

ANTIFUNGAL AGENT; LULICONAZOLE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ECZEMA; ERYTHEMA; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; POMPHOLYX; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; THERAPY EFFECT; TINEA PEDIS; TREATMENT INDICATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; TINEA PEDIS; TREATMENT OUTCOME;

FUNGI; TINEA PEDIS;

EID: 33845973714     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01305.x     Document Type: Article

References (30)

1. Shadomy S, Dixon DM, May R. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro. Sabouraudia 1982; 20: 313-23.
2. Yamaguchi H, Hiratani T, Plempel M. In vitro studies of a new antimycotic, bifonazole, in comparison with clotrimazole and miconazole. Arzneim-Forsch/Drug Res 1983; 33: 546-51.
3. Lackner TE, Clissold SP. Bifonazole; a review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs 1989; 38: 204-25.
4. Ohmi T, Konaka S, Uchida M, Yamaguchi H. Antifungal activity of the new agent lanoconazole in two tinea models. Arzneim-Forsch/Drug Res 1991; 41: 847-51.
5. Petranyi G, Ryder NS, Stitz A. Allylamine derivatives; new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984; 224: 1239-41.
6. Arika T, Yokoo M, Hase T, Maeda T, Amemia K, Yamaguchi H. Effects of butenafine hydrochloride. A new benzylamine derivative, on experimental dermatophytosis in guinea pig. Antimicrob Agents Chemother 1990; 34: 2250-3.
7. Stettemdorf S. Tolerability and efficacy of bifonazole in dermatomycoses. Arzneim-Forsch/Drug Res 1983; 33: 750-4.
8. Smith EB, Graham JL, Ulrich JA. Topical clotrimazole in tinea pedis. South Med J 1977; 70: 47-48.
9. Evans EG, Dodman B, Williamson DM, Brown GJ, Bowen RG. Comparison of terbinafine and clotrimazole in treating tinea pedis. Br Med J 1993; 307: 645-7.
10. Lesher JL, Babel DE, Stewart DM et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trail. J Am Acad Dermatol 1997; 36: S20-S24.
11. Wagner W, Reckers-Czaschka R. Oxiconazole in dermatomycosis - a double-blind, randomized therapy compared with bifonazole. Mykosen 1987; 30: 484-92.
12. Patel A, Brookman SD, Bullen MU et al. Topical treatment of interdigital tinea pedis: terbinafine compared clotrimazole. Australas J Dermatol 1999; 40: 197-200.
13. Kagawa S. Comparative clinical trial of naftifine and clotrimazole in tinea pedis, tinea cruris and tinea corporis. Mykosen 1985; 28(Suppl. 1): 82-88.
14. Jung EG, Bisco A, Azzollini E, Sartani A, Ruffmann R. Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. Dermatologica 1988; 177: 104-8.
15. Suschka S, Fladung B, Merk HF. Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. Mycoses 2002; 45: 91-96.
16. Kasai T. Epidemiological Investigation Committee for Human Mycoses, the Japanese Society for Medical Mycology (Co-chairman and Reporter: Kasai T.). 1997 Epidemiological survey of dermatophytoses in Japan. Jpn J Med Mycol 2001; 42: 11-18.
17. Watanabe S. Present state and future direction of topical antifungals. Jpn J Med Mycol 1999; 40: 151-5.
18. Niwano Y, Kuzuhara N, Kodama H, Yoshida M, Miyazaki T, Yamaguchi H. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Antimicrob Agents Chemother 1998; 42: 967-70.
19. Kagawa S. Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis. Clin Exp Dermatol 1989; 14: 114-5.
20. Uchida K, Tanaka T, Yamaguchi H. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis. Microbiol Immunol 2003; 47: 143-6.
21. Leenutaphong V. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis. J Med Assoc Thai 1999; 82: 1006-10.
22. Patel A, Brookman DD, Bullen MU et al. Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole. Australas J Dermatol 1999; 10: 197-200.
23. Schopf R, Brautigum HM, Weidinger G, Kaben U, Mauser P, Resl V. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial. Mycoses 1999; 42: 115-20.
24. Takahashi H. Liranaftate-cream-kenkyuhan, Liranaftate. Nishinihon-hifuka-zasshi 1993; 55: 747-58 (in Japanese).
25. Takahashi H. TJN-318cream-kennkyuhan, Lanoconazole. Nishinihon-hifuka- zasshi 1992; 54: 977-92 (in Japanese).
26. Kawaga S. MT-861-kenkyuhan, Amorolfine. Nishinihon-hifuka-zasshi 1992; 55: 101-758 (in Japanese).
27. Fukushiro R. Terbinafine-kenkyuhan, Terbinafine. Nishinihon-hifuka- zasshi 1991; 53: 1268-87 (in Japanese).
28. Kawaga S. SS717 Clinical Research Group, Clinical evaluation of SS717 cream in the treatment of dermatomycosis. Kisotorinsho 1991; 25: 415-46 (in Japanese).
29. Takahashi S. KCZ Cream Research Group, Clinical Evaluation of 2% Ketoconazole Cream in Superficial Mycoses. Kisotorinsho 1991; 25: 339-55 (in Japanese).
30. Fukushiro R. KP-363-kenkyuhan, Butenafine. Nishinihon-hifuka-zasshi 1990; 52: 1012-24 (in Japanese).